EDAP News Alert Edap Tms S.A. (EDAP) 3.55 02/14/2015 02:50:0

Edap Tms S.A. (EDAP) 3.55 $EDAP

The Top ADRs To Buy This Week
Todd Campbell - at Seeking Alpha - Thu Feb 12, 6:40AM CST

RUK: 71.70 (-1.02), BUD: 121.72 (-0.80), ANW: 14.92 (+0.25), DEG: 21.85 (-0.05), ENL: 50.46 (-0.66), FBR: 13.05 (-0.23), SNE: 27.30 (+0.19), TM: 132.49 (+0.67), RDY: 54.15 (-0.01), LUX: 58.79 (-1.11), OMAB: 38.76 (-0.66), TTM: 48.34 (+0.42), SNN: 35.82 (-0.28), RYAAY: 61.46 (-2.33), EDAP: 3.55 (+0.13), AZN: 69.96 (+0.20), TRIB: 17.30 (-0.12), EFA: 63.82 (+0.42), WX: 41.53 (+0.45), TEVA: 56.77 (-0.58)

Securities Lending Notable Names: JCP, AMBA
Interactive Brokers - at Seeking Alpha - Tue Jan 13, 2:32AM CST
Strong sales guidance gave some life to struggling department store operator, J.C. Penney Co., Inc. (NYSE: JCP ) last week following a prolonged period of negative news. The stock soared approximately 17% on Tuesday of last week after the company...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), EDAP: 3.55 (+0.13), LNCO: 12.30 (+0.28), IMRS: 1.04 (-0.03), GALT: 3.84 (+0.16), JCP: 8.05 (+0.14), MOC: 2.24 (+0.02), BIND: 6.06 (+0.21), LINE: 12.94 (+0.40), JOB: 0.79 (+0.01), BCLI: 3.86 (-0.02), NDRM: 10.76 (+0.22)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 11:47AM CST

EOPN: 8.55 (-0.01), ADHD: 6.92 (+0.73), CNAT: 5.92 (+0.10), ADMP: 6.50 (-0.01), FIVE: 33.01 (+0.11), TESO: 11.37 (+0.37), ALXA: 2.07 (+0.09), PRTO: 10.45 (unch), AGEN: 5.03 (-0.01), ARGS: 8.35 (-0.12), TOPS: 1.14 (+0.02), HILL: 4.42 (+0.06), EDAP: 3.55 (+0.13), CTSO: 8.20 (+0.18), VLCCF: 4.15 (-0.06), SCYX: 9.48 (+0.07), VIMC: 8.59 (-0.08), SBLK: 4.48 (+0.15), DCTH: 1.14 (+0.04), IDN: 1.43 (-0.01)

EDAP up big on Canadian approval
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 9:10AM CST

EDAP: 3.55 (+0.13)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 8:10AM CST

SD: 2.09 (+0.14), PTLA: 34.96 (+3.13), EOPN: 8.55 (-0.01), CNAT: 5.92 (+0.10), ADMP: 6.50 (-0.01), INFY: 36.60 (-0.13), FIVE: 33.01 (+0.11), AGEN: 5.03 (-0.01), SAN: 7.18 (+0.13), EDAP: 3.55 (+0.13), GMLP: 28.17 (+0.45), CTSO: 8.20 (+0.18), SBLK: 4.48 (+0.15), IDN: 1.43 (-0.01)

EDAP's Focal One HIFU Device Approved by Health Canada
GlobeNewswire - Fri Jan 09, 7:40AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its Focal One HIFU device has been approved by Health Canada. With this approval, the Company is able to market the Focal One device for the treatment of prostate cancer in Canada.
EDAP: 3.55 (+0.13)

EDAP gets a boost after earnings report
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 11:27AM CST

EDAP: 3.55 (+0.13)

EDAP TMS' (EDAP) CEO Marc Oczachowski on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 20, 9:56AM CST

EDAP: 3.55 (+0.13)

EDAP TMS S.A. (EDAP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 20, 7:25AM CST

EDAP: 3.55 (+0.13)

EDAP ups revenues 22% in Q3
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:17AM CST

EDAP: 3.55 (+0.13)

EDAP TMS S.A. EPS of $0.33
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:40AM CST

EDAP: 3.55 (+0.13)

EDAP Reports Continued Strong Growth in Third Quarter 2014
GlobeNewswire - Thu Nov 20, 6:30AM CST
Highlights
EDAP: 3.55 (+0.13)

EDAP's Ablatherm-HIFU PMA not approvable
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 9:52AM CST

EDAP: 3.55 (+0.13)

EDAP Receives FDA Guidance on PMA for Ablatherm-HIFU
GlobeNewswire - Thu Nov 06, 7:43AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today received a letter from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on its current PMA application for Ablatherm Integrated Imaging Device. The FDA letter stated that while EDAP's Ablatherm-HIFU PMA is not approvable in its current form, it provides specific guidance and recommendations as to a path forward. This guidance was provided in accordance with the requirements of 21 CFR 814.44(f), which states that the FDA, where practical, must identify measures necessary to make the PMA approvable.
EDAP: 3.55 (+0.13)

Edap reports November 20
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 11:22AM CST

EDAP: 3.55 (+0.13)

EDAP to Report Third Quarter 2014 Results on November 20, 2014
GlobeNewswire - Tue Nov 04, 7:30AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the third quarter ended September 30, 2014 on Thursday, November 20, 2014, during pre-market hours.
EDAP: 3.55 (+0.13)

EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France
GlobeNewswire - Tue Oct 21, 7:39AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale of a Focal One system to Nantes-Atlantis urology clinic, the top-ranked private prostate cancer clinic in France, and the country's only private clinic exclusively dedicated to urology.
EDAP: 3.55 (+0.13)

EDAP Presents Results of Its Ablatherm-HIFU FDA Study at 4th International Symposium of the Focused Ultrasound Foundation, Washington D.C.
GlobeNewswire - Mon Oct 13, 8:45AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that data on clinical outcomes of its Ablatherm-HIFU FDA study (the "Enlight Trial" will be presented at the 4 International Symposium of the Focused Ultrasound Foundation ("FUSF" , being held October 12-14, 2014 in Washington D.C. This symposium is the world's largest gathering of clinical and scientific experts in the area of focused ultrasound, and a forum for the latest clinical advances in image-guided focused ultrasound applications across a variety of therapeutic areas.
EDAP: 3.55 (+0.13)